Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-06
2007-02-06
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S232200, C514S254010, C514S422000, C514S423000, C540S602000, C544S082000, C544S372000, C548S524000
Reexamination Certificate
active
10482700
ABSTRACT:
Compounds of the formula (I),wherein the symbol aa means a residue of an α-amino acid. The invention is also directed to a method for the preparation of the compounds of formula (I), as well as their use as prolyl oligopeptide inhibitors, for example for the treatment of Alzheimer's disease.
REFERENCES:
patent: 6103910 (2000-08-01), Hertel et al.
patent: 6121311 (2000-09-01), Matsubara et al.
patent: 6512001 (2003-01-01), Hertel et al.
patent: 0 468 339 (1992-01-01), None
patent: 0 915 088 (1999-05-01), None
patent: WO 91/18891 (1991-12-01), None
Kogiso, et al. “Dicarboxylic Oligopeptide Bolaamphiphiles: Proton-Triggered Self-Assembly of Microtubes with Loose Solid Surfaces” Langmuir, vol. 14, pp. 4978-4986 (1998).
Fiona M. Anderson et al., “Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents,” Anti-Cancer Drug Design, vol. 15, 2000, pp. 119-126.
N. A. Grigoryan et al., “Synthesis and antistaphylococcal activity of dicarboxylic acid derivatives containing an amino acid fragment,” Chemical Abstracts, vol. 117, Oct. 26, 1992.
L. Colombo et al., “Enantioselective Synthesis of Secondary Alcohols in the Presence of Chiral Ligands,” Tetrahedron, vol. 38, No. 17, 1982, pp. 2725-2727.
Sherwin Wilk, “Minireview Prolyl Endopeptidase,” Life Sciences, vol. 33, 1983, pp. 2149-2157.
Rhonda O'Leary et al., “Thyrotropin-Releasing Hormone,” Journal of Neurochemistry, vol. 65, No. 3, 1995, pp. 953-963.
Tadashi Yoshimoto et al., “Specific Inhibitors for Prolyl Endopeptidase And Their Anti-Amnesic Effect,” J. Pharmacobio-Dyn, vol. 10, 1987, pp. 730-735.
Neil W. Kowall et al., “An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P,” Proc. Natl. Acad. Sci. USA, vol. 88, 1991, pp. 7247-7251, Aug. 1991.
Katsuo Toide et al., “JTP-4819: A Novel Prolyl Endopeptidase Inhibitor with Potential as a Cognitive Enhancer,” J. Pharmacol. Exp. Ther., 1995, vol. 274, pp. 1370-1378.
Guillaume DeNanteuil et al., “Prolyl endopeptidase inhibitors: a new class of memory enhancing drugs,” J. Drugs Fut., 1998, vol. 23, pp. 167-179.
Beilstein Data: Beilstein Registry No. 1805844, Beilstein Institut zur Foerderung der Chemischen Wissenschaften, copyright 1988-2005.
Beilstein Data: Beilstein Registry No. 8705350, Beilstein Institut zur Foerderung der Chemischen Wissenschaften, copyright 1988-2005.
Beilstein Data: Beilstein Registry No. 1803243, Beilstein Institut zur Foerderung der Chemischen Wissenschaften, copyright 1988-2005.
Beilstein Data: Beilstein Registry No. 6503093, Beilstein Institut zur Foerderung der Chemischen Wissenschaften, copyright 1988-2005.
Beilstein Data: Beilstein Registry No. 3484140, Beilstein Institut zur Foerderung der Chemischen Wissenschaften, copyright 1988-2005.
Beilstein Data: Beilstein Registry No. 2483846, Beilstein Institut zur Foerderung der Chemischen Wissenschaften, copyright 1988-2005.
Beilstein Data: Beilstein Registry No. 4023304, Beilstein Institut zur Foerderung der Chemischen Wissenschaften, copyright 1988-2005.
Beilstein Data: Beilstein Registry No. 7312852, Beilstein Institut zur Foerderung der Chemischen Wissenschaften, copyright 1988-2005.
Beilstein Data: Beilstein Registry No. 2404859, Beilstein Institut zur Foerderung der Chemischen Wissenschaften, copyright 1988-2005.
Christiaans Johannes
Forsberg Markus
Gynther Jukka
Jarho Elina
Männistö Pekka
Finnegan Henderson Farabow Garrett & Dunner LLP
Grazier Nyeemah
McKane Joseph K.
Orion Corporation
LandOfFree
Compounds having prolyl oligopeptidase inhibitory activity,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having prolyl oligopeptidase inhibitory activity,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having prolyl oligopeptidase inhibitory activity,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3880047